Dr. Parikh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 E Medical Center Dr
3rd Floor Taubman Center Recp D
Ann Arbor, MI 48109Phone+1 734-647-5944Fax+1 734-936-5458
Education & Training
- McGaw Medical Center of Northwestern UniversityFellowship, Transplant Hepatology, 2012 - 2013
- McGaw Medical Center of Northwestern UniversityFellowship, Gastroenterology, 2009 - 2012
- Northwestern University The Feinberg School of MedicineM.S., Health Services & Outcomes Research, 2008 - 2012
- McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 2005 - 2008
- University of Virginia School of MedicineClass of 2005
- University of Maryland, College ParkB.S., Microbiology, With honors, 1997 - 2001
Certifications & Licensure
- MI State Medical License 2013 - 2026
- IL State Medical License 2005 - 2014
- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Poster of Distinction American Transplant Congress, 2008
- Medical Student Teaching Award Northwestern University Department of Medicine, 2005-2006
- Join now to see all
Clinical Trials
- A Longitudinal Observational Study of the Natural History and Management of Patients With HCC Start of enrollment: 2016 Dec 01
Roles: Contact
Publications & Presentations
PubMed
- 126 citationsPatient‐reported barriers are associated with lower hepatocellular carcinoma surveillance rates in patients with cirrhosisSherean Farvardin, Jaimin Patel, Maleka Khambaty, Olutola A. Yerokun, Huram Mok
Hepatology. 2017-03-01 - 553 citationsMortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational studyElliot B. Tapper, Neehar D. Parikh
BMJ. 2018-07-18 - 267 citationsRacial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis.Nicole E. Rich, Stefany Oji, Arjmand R. Mufti, Jeffrey D. Browning, Neehar D. Parikh
Clinical Gastroenterology and Hepatology. 2017-09-29
Journal Articles
- Frailty, Psychoactive Medications, and Cognitive Dysfunction Are Associated with Poor Patient‐Reported Outcomes in CirrhosisElliot B Tapper, Neehar D Parikh, Anna S Lok, Hepatology
- Effectiveness and Cost of Radiofrequency Ablation and Stereotactic Body Radiotherapy for Treatment of Early‐Stage Hepatocellular Carcinoma: An Analysis of SEER‐MedicareAmit G Singal, Neehar D Parikh, Theodore S Lawrence, Nataliya Razumilava, Journal of Medical Imaging and Radiation Oncology
- Radiologist Quality Assurance by Nonradiologists at Tumor BoardWilliam R Masch, Neehar D Parikh, Journal of the American College of Radiology
Books/Book Chapters
Abstracts/Posters
- Analytic Morphomics Predicts Survival in Patients with Hepatocellular Carcinoma Treated with Transarterial ChemoembolizationParikh ND, Singal AG, Zhang P, Krishnamurthy V, Barman P, Waljee AK, Su GL, American Association for the Study of Liver Diseases Meeting, San Francisco, CA, 1/1/2015
- Prevalence of hepatitis B core antibody (anti-HBc) and association with hepatocellular carcinoma (HCC) in patients with chronic hepatitis C virus (HCV) infection in th...Yang M, Wu E, Fu S, Rao H, Feng B, Lin A, Fei R, Parikh ND, Fontana RJ, Lok AS, Wei L, American Association for the Study of Liver Diseases Meeting, San Francisco, CA, 1/1/2015
- Survival Of Patients With Advanced Hepatocellular Carcinoma On Sorafenib: An Analysis Of SEER-Medicare DatabaseParikh ND, Marshall V, Balkrishnan R, Shahinian V, International Liver Cancer Association Annual Conference, Paris, France, 1/1/2015
- Join now to see all
Lectures
- Comparative efficacy of second-line treatments for advanced hepatocellular carcinoma: A network meta-analysis.ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020
- Reinterpretation of outside hospital MRI abdomen exams in patients with cirrhosis: Is the OPTN mandate necessary?Waikoloa, HI - 1/1/2016
- The Impact of US Population Demographic Shifts on Organ Availability for Transplantation1/1/2015
- Join now to see all
Authored Content
- Radiologist Quality Assurance by Nonradiologists at Tumor BoardJune 2018
Press Mentions
- Noninvasive Model Minimizes the Risk for Missing High-Risk Varices in Unresectable HCCAugust 15th, 2024
- Does Public Policy Affect Alcohol-Related Liver Disease Deaths?April 13th, 2021
- Comparison of Seven Noninvasive Models for Predicting Decompensation and Hospitalization in Patients with CirrhosisJanuary 2nd, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: